Effect of antitumor treatments on triple-negative breast cancer patients: A PRISMA-compliant network meta-analysis of randomized controlled trials

BACKGROUND: Triple-negative breast cancer (TNBC) lacks the expression of the estrogen receptor, progesterone receptor, and receptor tyrosine-protein kinase erbB-2 (HER2/neu), which renders hormone-related endocrine and targeted therapy essentially futile. OBJECTIVE: We performed a meta-analysis to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Qiuhong, Du, Peng, Li, Sen, Bai, Zhenzhu, Yang, Yong, Zeng, Jinsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690714/
https://www.ncbi.nlm.nih.gov/pubmed/29137021
http://dx.doi.org/10.1097/MD.0000000000008389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690714/
https://www.ncbi.nlm.nih.gov/pubmed/29137021
http://dx.doi.org/10.1097/MD.0000000000008389

Ejemplares similares